pmid,date,mesh,journal,affil,athrs,pt,gr
36328372,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>07</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D000328"" MajorTopicYN=""N"">Adult</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008875"" MajorTopicYN=""N"">Middle Aged</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D005260"" MajorTopicYN=""N"">Female</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D013530"" MajorTopicYN=""N"">Surgical Wound Infection</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003107"" MajorTopicYN=""Y"">Colorectal Surgery</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D009950"" MajorTopicYN=""Y"">Ornidazole</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019072"" MajorTopicYN=""N"">Antibiotic Prophylaxis</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000900"" MajorTopicYN=""N"">Anti-Bacterial Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000890"" MajorTopicYN=""Y"">Anti-Infective Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004311"" MajorTopicYN=""N"">Double-Blind Method</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <PubDate>      <Year>2022</Year>      <Month>11</Month>      <Day>03</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Département Anesthésie et Réanimation, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France efutier@chu-clermontferrand.fr.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Futier</LastName>    <ForeName>Emmanuel</ForeName>    <Initials>E</Initials>    <Identifier Source=""ORCID"">0000-0002-6454-271X</Identifier>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France efutier@chu-clermontferrand.fr.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Inserm U-1103, CNRS UMR 6293, Université Clermont Auvergne, Clermont-Ferrand, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jaber</LastName>    <ForeName>Samir</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation B, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint-Eloi, Montpellier, France.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Inserm U-1046, Université Montpellier, Montpellier, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Garot</LastName>    <ForeName>Matthias</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Pôle Anesthésie Réanimation, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Lille, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vignaud</LastName>    <ForeName>Marie</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Panis</LastName>    <ForeName>Yves</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Département de Chirurgie Colorectale, Assistance publique-Hôpitaux de Paris, Pôle des Maladies de l'Appareil Digestif, Hôpital Beaujon, Clichy, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Slim</LastName>    <ForeName>Karem</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>Service de Chirurgie Digestive et Hépatobiliaire, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lucet</LastName>    <ForeName>Jean-Christophe</ForeName>    <Initials>JC</Initials>    <AffiliationInfo>      <Affiliation>Unité d'Hygiène et de Lutte Contre les Infections Nosocomiales, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>IAME, Université Paris Sorbonne Nord, UMR 1137 Inserm, Paris, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lebuffe</LastName>    <ForeName>Gilles</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Pôle Anesthésie Réanimation, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Lille, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ouattara</LastName>    <ForeName>Alexandre</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Service Anesthésie et Réanimation, Centre Medico-chirurgical Magellan, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Biologie des Maladies Cardiovasculaires, Université de Bordeaux, UMR 1034 Inserm, Pessac, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>El Amine</LastName>    <ForeName>Younes</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation, Centre Hospitalier de Valenciennes, Valenciennes, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Couderc</LastName>    <ForeName>Philippe</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Service de Chirurgie Viscérale et Digestive, Centre Hospitalier de Pau, Pau, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dupré</LastName>    <ForeName>Aurélien</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Département de chirurgie oncologique, Centre Léon Bérard, Lyon, France.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Inserm, LabTAU, Université Claude Bernard Lyon 1, Lyon, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>De Jong</LastName>    <ForeName>Audrey</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation B, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint-Eloi, Montpellier, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lasocki</LastName>    <ForeName>Sigismond</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie et Réanimation, Centre Hospitalier Universitaire de Angers, Angers, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leone</LastName>    <ForeName>Marc</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Service Anesthésie et Réanimation, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Hôpital Nord, Marseille, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pottecher</LastName>    <ForeName>Julien</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Service d'Anesthésie Réanimation et Médecine Périopératoire, Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre, Strasbourg, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pereira</LastName>    <ForeName>Bruno</ForeName>    <Initials>B</Initials>    <AffiliationInfo>      <Affiliation>Direction de la Recherche Clinique, Centre Hospitalier Universitaire de Clermont-Ferrand, Biostatistics Unit, Clermont-Ferrand, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paugam-Burtz</LastName>    <ForeName>Catherine</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Département Anesthésie Réanimation, Assistance publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Nord Val de Seine, Hôpital Beaujon, Clichy, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>COMBINE study group</CollectiveName>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016449"">Randomized Controlled Trial</PublicationType>  <PublicationType UI=""D016448"">Multicenter Study</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36329272,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>11</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D000086382"" MajorTopicYN=""Y"">COVID-19</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D058873"" MajorTopicYN=""N"">Pandemics</DescriptorName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D011634"" MajorTopicYN=""N"">Public Health</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D003697"" MajorTopicYN=""N"">Delphi Technique</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D006076"" MajorTopicYN=""N"">Government</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1476-4687</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>611</Volume>    <Issue>7935</Issue>    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>    </PubDate>  </JournalIssue>  <Title>Nature</Title>  <ISOAbbreviation>Nature</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Jeffrey.Lazarus@isglobal.org.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Lazarus</LastName>    <ForeName>Jeffrey V</ForeName>    <Initials>JV</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0001-9618-2299</Identifier>    <AffiliationInfo>      <Affiliation>Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Jeffrey.Lazarus@isglobal.org.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. Jeffrey.Lazarus@isglobal.org.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York City, NY, USA. Jeffrey.Lazarus@isglobal.org.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Romero</LastName>    <ForeName>Diana</ForeName>    <Initials>D</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-4832-9564</Identifier>    <AffiliationInfo>      <Affiliation>City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York City, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kopka</LastName>    <ForeName>Christopher J</ForeName>    <Initials>CJ</Initials>    <AffiliationInfo>      <Affiliation>Independent Researcher, Sioux Falls, SD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Karim</LastName>    <ForeName>Salim Abdool</ForeName>    <Initials>SA</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-4986-2133</Identifier>    <AffiliationInfo>      <Affiliation>University of KwaZulu-Natal, Durban, South Africa.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, South Africa.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Abu-Raddad</LastName>    <ForeName>Laith J</ForeName>    <Initials>LJ</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-0790-0506</Identifier>    <AffiliationInfo>      <Affiliation>Weill Cornell Medicine, Cornell University, Ithaca, NY, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Almeida</LastName>    <ForeName>Gisele</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Pan American Health Organisation, Washington, DC, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Baptista-Leite</LastName>    <ForeName>Ricardo</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>UNITE Global Parliamentarians Network, Lisbon, Portugal.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Health Sciences (CIIS), Catholic University of Portugal, Lisbon, Portugal.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barocas</LastName>    <ForeName>Joshua A</ForeName>    <Initials>JA</Initials>    <AffiliationInfo>      <Affiliation>University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barreto</LastName>    <ForeName>Mauricio L</ForeName>    <Initials>ML</Initials>    <AffiliationInfo>      <Affiliation>Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>University of Bahia, Salvador, Brazil.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bar-Yam</LastName>    <ForeName>Yaneer</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>New England Complex Systems Institute, Cambridge, MA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bassat</LastName>    <ForeName>Quique</ForeName>    <Initials>Q</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-0875-7596</Identifier>    <AffiliationInfo>      <Affiliation>Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Manhiça Health Research Center (CISM), Maputo, Mozambique.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Catalan Institute for Research and Advanced Studies (ICREA), Barcelona, Spain.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Pediatrics Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Biomedical Research Consortium in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Batista</LastName>    <ForeName>Carolina</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Doctors Without Borders (MSF), Geneva, Switzerland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Baraka Impact Finance, Geneva, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bazilian</LastName>    <ForeName>Morgan</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Payne Institute, Colorado School of Mines, Golden, CO, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chiou</LastName>    <ForeName>Shu-Ti</ForeName>    <Initials>ST</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-6994-1891</Identifier>    <AffiliationInfo>      <Affiliation>National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Del Rio</LastName>    <ForeName>Carlos</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Emory School of Medicine, Atlanta, GA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dore</LastName>    <ForeName>Gregory J</ForeName>    <Initials>GJ</Initials>    <AffiliationInfo>      <Affiliation>University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gao</LastName>    <ForeName>George F</ForeName>    <Initials>GF</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-3869-615X</Identifier>    <AffiliationInfo>      <Affiliation>Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gostin</LastName>    <ForeName>Lawrence O</ForeName>    <Initials>LO</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0001-5286-4044</Identifier>    <AffiliationInfo>      <Affiliation>The O'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hellard</LastName>    <ForeName>Margaret</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Burnet Institute, Melbourne, Victoria, Australia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jimenez</LastName>    <ForeName>Jose L</ForeName>    <Initials>JL</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0001-6203-1847</Identifier>    <AffiliationInfo>      <Affiliation>Department of Chemistry, University of Colorado Boulder, Boulder, CO, USA.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Cooperative Institute for Research in Environmental Sciences (CIRES), University of Colorado Boulder, Boulder, CO, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kang</LastName>    <ForeName>Gagandeep</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Christian Medical College (CMC), Vellore, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lee</LastName>    <ForeName>Nancy</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Wilton Park, Steyning, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Matičič</LastName>    <ForeName>Mojca</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre, Ljubljana, Slovenia.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McKee</LastName>    <ForeName>Martin</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-0121-9683</Identifier>    <AffiliationInfo>      <Affiliation>The London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nsanzimana</LastName>    <ForeName>Sabin</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>University Teaching Hospital of Butare, Butare, Rwanda.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Oliu-Barton</LastName>    <ForeName>Miquel</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-1793-6350</Identifier>    <AffiliationInfo>      <Affiliation>Paris Dauphine University - PSL, Paris, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pradelski</LastName>    <ForeName>Bary</ForeName>    <Initials>B</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-2418-0037</Identifier>    <AffiliationInfo>      <Affiliation>French National Centre for Scientific Research (CNRS), Grenoble, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pyzik</LastName>    <ForeName>Oksana</ForeName>    <Initials>O</Initials>    <AffiliationInfo>      <Affiliation>University College London (UCL), London, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rabin</LastName>    <ForeName>Kenneth</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York City, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Raina</LastName>    <ForeName>Sunil</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Dr. Rajendra Prasad Government Medical College, Himachal Pradesh, India.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rashid</LastName>    <ForeName>Sabina Faiz</ForeName>    <Initials>SF</Initials>    <AffiliationInfo>      <Affiliation>James P. Grant School of Public Health, BRAC University, Dhaka, Bangladesh.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rathe</LastName>    <ForeName>Magdalena</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-5095-748X</Identifier>    <AffiliationInfo>      <Affiliation>Plenitud Foundation, Santo Domingo, Dominican Republic.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Saenz</LastName>    <ForeName>Rocio</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>University of Costa Rica, San José, Costa Rica.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Singh</LastName>    <ForeName>Sudhvir</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Trock-Hempler</LastName>    <ForeName>Malene</ForeName>    <Initials>M</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0003-4492-3256</Identifier>    <AffiliationInfo>      <Affiliation>Independent Philosopher, Copenhagen, Denmark.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Villapol</LastName>    <ForeName>Sonia</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurosurgery, Houston Methodist Research Institute, Houston, TX, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yap</LastName>    <ForeName>Peiling</ForeName>    <Initials>P</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-5964-8210</Identifier>    <AffiliationInfo>      <Affiliation>International Digital Health &amp; AI Research Collaborative (I-DAIR), Geneva, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Binagwaho</LastName>    <ForeName>Agnes</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-6779-3151</Identifier>    <AffiliationInfo>      <Affiliation>University of Global Health Equity, Kigali, Rwanda.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kamarulzaman</LastName>    <ForeName>Adeeba</ForeName>    <Initials>A</Initials>    <Identifier Source=""ORCID"">http://orcid.org/0000-0002-8074-4450</Identifier>    <AffiliationInfo>      <Affiliation>University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>El-Mohandes</LastName>    <ForeName>Ayman</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York City, NY, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <CollectiveName>COVID-19 Consensus Statement Panel</CollectiveName>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36331190,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1533-4406</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>The New England journal of medicine</Title>  <ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <CollectiveName>EMPA-KIDNEY Collaborative Group</CollectiveName>  </Author>  <Author ValidYN=""Y"">    <LastName>Herrington</LastName>    <ForeName>William G</ForeName>    <Initials>WG</Initials>    <Identifier Source=""ORCID"">0000-0003-1172-8243</Identifier>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Staplin</LastName>    <ForeName>Natalie</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wanner</LastName>    <ForeName>Christoph</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Green</LastName>    <ForeName>Jennifer B</ForeName>    <Initials>JB</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hauske</LastName>    <ForeName>Sibylle J</ForeName>    <Initials>SJ</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Emberson</LastName>    <ForeName>Jonathan R</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Preiss</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Judge</LastName>    <ForeName>Parminder</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mayne</LastName>    <ForeName>Kaitlin J</ForeName>    <Initials>KJ</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ng</LastName>    <ForeName>Sarah Y A</ForeName>    <Initials>SYA</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sammons</LastName>    <ForeName>Emily</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhu</LastName>    <ForeName>Doreen</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hill</LastName>    <ForeName>Michael</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Stevens</LastName>    <ForeName>Will</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wallendszus</LastName>    <ForeName>Karl</ForeName>    <Initials>K</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brenner</LastName>    <ForeName>Susanne</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cheung</LastName>    <ForeName>Alfred K</ForeName>    <Initials>AK</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Zhi-Hong</ForeName>    <Initials>ZH</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Jing</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hooi</LastName>    <ForeName>Lai Seong</ForeName>    <Initials>LS</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Wen</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kadowaki</LastName>    <ForeName>Takashi</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Nangaku</LastName>    <ForeName>Masaomi</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Levin</LastName>    <ForeName>Adeera</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cherney</LastName>    <ForeName>David</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Maggioni</LastName>    <ForeName>Aldo P</ForeName>    <Initials>AP</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Pontremoli</LastName>    <ForeName>Roberto</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deo</LastName>    <ForeName>Rajat</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Goto</LastName>    <ForeName>Shinya</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rossello</LastName>    <ForeName>Xavier</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tuttle</LastName>    <ForeName>Katherine R</ForeName>    <Initials>KR</Initials>    <Identifier Source=""ORCID"">0000-0002-2235-0103</Identifier>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Steubl</LastName>    <ForeName>Dominik</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Petrini</LastName>    <ForeName>Michaela</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Massey</LastName>    <ForeName>Dan</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Eilbracht</LastName>    <ForeName>Jens</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Brueckmann</LastName>    <ForeName>Martina</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Landray</LastName>    <ForeName>Martin J</ForeName>    <Initials>MJ</Initials>    <Identifier Source=""ORCID"">0000-0001-6646-827X</Identifier>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Baigent</LastName>    <ForeName>Colin</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Haynes</LastName>    <ForeName>Richard</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>","<GrantList CompleteYN=""Y"">  <Grant>    <GrantID>MC_UU_00017/3 &amp; MR/R007764/1</GrantID>    <Acronym>MRC_</Acronym>    <Agency>Medical Research Council</Agency>    <Country>United Kingdom</Country>  </Grant>  <Grant>    <GrantID>MR/R007764/1</GrantID>    <Agency>Kidney Research UK</Agency>    <Country/>  </Grant></GrantList>"
36331445,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Harvard T.H. Chan School of Public Health, Harvard Kennedy School, Boston, Massachusetts.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Koh</LastName>    <ForeName>Howard K</ForeName>    <Initials>HK</Initials>    <AffiliationInfo>      <Affiliation>Harvard T.H. Chan School of Public Health, Harvard Kennedy School, Boston, Massachusetts.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Fiore</LastName>    <ForeName>Michael C</ForeName>    <Initials>MC</Initials>    <AffiliationInfo>      <Affiliation>University of Wisconsin-Madison Center for Tobacco Research and Intervention, Madison.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36331491,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1538-3598</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>JAMA</Title>  <ISOAbbreviation>JAMA</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Population and Public Health Sciences and Institute for Addiction Science, Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Harlow</LastName>    <ForeName>Alyssa F</ForeName>    <Initials>AF</Initials>    <AffiliationInfo>      <Affiliation>Department of Population and Public Health Sciences and Institute for Addiction Science, Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Leventhal</LastName>    <ForeName>Adam M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Department of Population and Public Health Sciences and Institute for Addiction Science, Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Barrington-Trimis</LastName>    <ForeName>Jessica L</ForeName>    <Initials>JL</Initials>    <AffiliationInfo>      <Affiliation>Department of Population and Public Health Sciences and Institute for Addiction Science, Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36332637,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Ahmad</LastName>    <ForeName>Ehtasham</ForeName>    <Initials>E</Initials>    <AffiliationInfo>      <Affiliation>Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lim</LastName>    <ForeName>Soo</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Lamptey</LastName>    <ForeName>Roberta</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Family Medicine Department, Korle Bu Teaching Hospital, Accra Ghana and Community Health Department, University of Ghana Medical School, Accra, Ghana.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Webb</LastName>    <ForeName>David R</ForeName>    <Initials>DR</Initials>    <AffiliationInfo>      <Affiliation>Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Davies</LastName>    <ForeName>Melanie J</ForeName>    <Initials>MJ</Initials>    <AffiliationInfo>      <Affiliation>Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Leicester, UK. Electronic address: melanie.davies@uhl-tr.nhs.uk.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType>  <PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList>",NA
36332911,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008499"" MajorTopicYN=""Y"">Medical Records</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D004739"" MajorTopicYN=""N"" Type=""Geographic"">England</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D033283"" MajorTopicYN=""Y"">Patient Access to Records</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>",<AffiliationInfo>  <Affiliation>London.</Affiliation></AffiliationInfo>,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Limb</LastName>    <ForeName>Matthew</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>London.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36332912,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D008297"" MajorTopicYN=""N"">Male</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D065129"" MajorTopicYN=""Y"">Pre-Exposure Prophylaxis</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D019380"" MajorTopicYN=""Y"">Anti-HIV Agents</DescriptorName>    <QualifierName UI=""Q000627"" MajorTopicYN=""N"">therapeutic use</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D015658"" MajorTopicYN=""Y"">HIV Infections</DescriptorName>    <QualifierName UI=""Q000453"" MajorTopicYN=""N"">epidemiology</QualifierName>    <QualifierName UI=""Q000517"" MajorTopicYN=""N"">prevention &amp; control</QualifierName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D018451"" MajorTopicYN=""N"">Homosexuality, Male</DescriptorName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>",<AffiliationInfo>  <Affiliation>London.</Affiliation></AffiliationInfo>,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Griffin</LastName>    <ForeName>Shaun</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>London.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36332922,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>09</Day></DateCompleted>,NA,"<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>379</Volume>    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>04</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>",<AffiliationInfo>  <Affiliation>The BMJ.</Affiliation></AffiliationInfo>,"<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Iacobucci</LastName>    <ForeName>Gareth</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>The BMJ.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36333100,<DateCompleted>  <Year>2022</Year>  <Month>11</Month>  <Day>08</Day></DateCompleted>,"<MeshHeadingList>  <MeshHeading>    <DescriptorName UI=""D006801"" MajorTopicYN=""N"">Humans</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D055676"" MajorTopicYN=""Y"">Viscosupplementation</DescriptorName>    <QualifierName UI=""Q000009"" MajorTopicYN=""N"">adverse effects</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D020370"" MajorTopicYN=""Y"">Osteoarthritis, Knee</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010147"" MajorTopicYN=""N"">Pain Measurement</DescriptorName>  </MeshHeading>  <MeshHeading>    <DescriptorName UI=""D010146"" MajorTopicYN=""N"">Pain</DescriptorName>    <QualifierName UI=""Q000188"" MajorTopicYN=""N"">drug therapy</QualifierName>  </MeshHeading></MeshHeadingList>","<Journal>  <ISSN IssnType=""Electronic"">1756-1833</ISSN>  <JournalIssue CitedMedium=""Internet"">    <Volume>378</Volume>    <PubDate>      <Year>2022</Year>      <Month>07</Month>      <Day>06</Day>    </PubDate>  </JournalIssue>  <Title>BMJ (Clinical research ed.)</Title>  <ISOAbbreviation>BMJ</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Pereira</LastName>    <ForeName>Tiago V</ForeName>    <Initials>TV</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jüni</LastName>    <ForeName>Peter</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Saadat</LastName>    <ForeName>Pakeezah</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Xing</LastName>    <ForeName>Dan</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Arthritis Clinic &amp; Research Centre, Peking University People's Hospital, Beijing, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Yao</LastName>    <ForeName>Liang</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bobos</LastName>    <ForeName>Pavlos</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Health and Rehabilitation Sciences, School of Physical Therapy, Western University, London, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Agarwal</LastName>    <ForeName>Arnav</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Hincapié</LastName>    <ForeName>Cesar A</ForeName>    <Initials>CA</Initials>    <AffiliationInfo>      <Affiliation>Department of Chiropractic Medicine, Faculty of Medicine, Balgrist University Hospital and University of Zurich, Zurich, Switzerland.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>da Costa</LastName>    <ForeName>Bruno R</ForeName>    <Initials>BR</Initials>    <Identifier Source=""ORCID"">0000-0002-1786-6332</Identifier>    <AffiliationInfo>      <Affiliation>Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada bruno.dacosta@utoronto.ca.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation>    </AffiliationInfo>    <AffiliationInfo>      <Affiliation>Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D017418"">Meta-Analysis</PublicationType>  <PublicationType UI=""D000078182"">Systematic Review</PublicationType>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36334588,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>01</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Chirila</LastName>    <ForeName>Anda M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rankin</LastName>    <ForeName>Genelle</ForeName>    <Initials>G</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tseng</LastName>    <ForeName>Shih-Yi</ForeName>    <Initials>SY</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Emanuel</LastName>    <ForeName>Alan J</ForeName>    <Initials>AJ</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chavez-Martinez</LastName>    <ForeName>Carmine L</ForeName>    <Initials>CL</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Dawei</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Harvey</LastName>    <ForeName>Christopher D</ForeName>    <Initials>CD</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ginty</LastName>    <ForeName>David D</ForeName>    <Initials>DD</Initials>    <AffiliationInfo>      <Affiliation>Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA. Electronic address: david_ginty@hms.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36334589,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: haopeng_xiao@dfci.harvard.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Xiao</LastName>    <ForeName>Haopeng</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: haopeng_xiao@dfci.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bozi</LastName>    <ForeName>Luiz H M</ForeName>    <Initials>LHM</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sun</LastName>    <ForeName>Yizhi</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Riley</LastName>    <ForeName>Christopher L</ForeName>    <Initials>CL</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Philip</LastName>    <ForeName>Vivek M</ForeName>    <Initials>VM</Initials>    <AffiliationInfo>      <Affiliation>The Jackson Laboratory, Bar Harbor, ME 04609, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Mandy</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>The Jackson Laboratory, Bar Harbor, ME 04609, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Li</LastName>    <ForeName>Jiaming</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Tian</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Mills</LastName>    <ForeName>Evanna L</ForeName>    <Initials>EL</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Emont</LastName>    <ForeName>Margo P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Sun</LastName>    <ForeName>Wenfei</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Bioengineering, Stanford University, CA 94305, USA; Department of Molecular and Cellular Physiology, Stanford University, CA 94305, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Reddy</LastName>    <ForeName>Anita</ForeName>    <Initials>A</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Garrity</LastName>    <ForeName>Ryan</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Long</LastName>    <ForeName>Jiani</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>College of Computing, Georgia Institute of Technology, Atlanta, GA 30332, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Becher</LastName>    <ForeName>Tobias</ForeName>    <Initials>T</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY 10065, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Vitas</LastName>    <ForeName>Laura Potano</ForeName>    <Initials>LP</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Laznik-Bogoslavski</LastName>    <ForeName>Dina</ForeName>    <Initials>D</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Ordonez</LastName>    <ForeName>Martha</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Xinyue</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chen</LastName>    <ForeName>Xiong</ForeName>    <Initials>X</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Yun</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong 510275, China.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Weihai</ForeName>    <Initials>W</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tran</LastName>    <ForeName>Nhien</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Liu</LastName>    <ForeName>Yitong</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Zhang</LastName>    <ForeName>Yang</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cypess</LastName>    <ForeName>Aaron M</ForeName>    <Initials>AM</Initials>    <AffiliationInfo>      <Affiliation>Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>White</LastName>    <ForeName>Andrew P</ForeName>    <Initials>AP</Initials>    <AffiliationInfo>      <Affiliation>Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>He</LastName>    <ForeName>Yuchen</ForeName>    <Initials>Y</Initials>    <AffiliationInfo>      <Affiliation>Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Deng</LastName>    <ForeName>Rebecca</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Schöder</LastName>    <ForeName>Heiko</ForeName>    <Initials>H</Initials>    <AffiliationInfo>      <Affiliation>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Paulo</LastName>    <ForeName>Joao A</ForeName>    <Initials>JA</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jedrychowski</LastName>    <ForeName>Mark P</ForeName>    <Initials>MP</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Banks</LastName>    <ForeName>Alexander S</ForeName>    <Initials>AS</Initials>    <AffiliationInfo>      <Affiliation>Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tseng</LastName>    <ForeName>Yu-Hua</ForeName>    <Initials>YH</Initials>    <AffiliationInfo>      <Affiliation>Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Cohen</LastName>    <ForeName>Paul</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY 10065, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Tsai</LastName>    <ForeName>Linus T</ForeName>    <Initials>LT</Initials>    <AffiliationInfo>      <Affiliation>Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Rosen</LastName>    <ForeName>Evan D</ForeName>    <Initials>ED</Initials>    <AffiliationInfo>      <Affiliation>Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Klein</LastName>    <ForeName>Samuel</ForeName>    <Initials>S</Initials>    <AffiliationInfo>      <Affiliation>Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chondronikola</LastName>    <ForeName>Maria</ForeName>    <Initials>M</Initials>    <AffiliationInfo>      <Affiliation>Department of Nutrition, UC Davis, Davis, CA 95616, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>McAllister</LastName>    <ForeName>Fiona E</ForeName>    <Initials>FE</Initials>    <AffiliationInfo>      <Affiliation>Calico Life Sciences LLC, South San Francisco, CA 94080, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Van Bruggen</LastName>    <ForeName>Nick</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Calico Life Sciences LLC, South San Francisco, CA 94080, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Huttlin</LastName>    <ForeName>Edward L</ForeName>    <Initials>EL</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Spiegelman</LastName>    <ForeName>Bruce M</ForeName>    <Initials>BM</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Churchill</LastName>    <ForeName>Gary A</ForeName>    <Initials>GA</Initials>    <AffiliationInfo>      <Affiliation>The Jackson Laboratory, Bar Harbor, ME 04609, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Gygi</LastName>    <ForeName>Steven P</ForeName>    <Initials>SP</Initials>    <AffiliationInfo>      <Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Chouchani</LastName>    <ForeName>Edward T</ForeName>    <Initials>ET</Initials>    <AffiliationInfo>      <Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: edwardt_chouchani@dfci.harvard.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36334590,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1097-4172</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Cell</Title>  <ISOAbbreviation>Cell</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Wang</LastName>    <ForeName>Jinfan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Shin</LastName>    <ForeName>Byung-Sik</ForeName>    <Initials>BS</Initials>    <AffiliationInfo>      <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Alvarado</LastName>    <ForeName>Carlos</ForeName>    <Initials>C</Initials>    <AffiliationInfo>      <Affiliation>Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Kim</LastName>    <ForeName>Joo-Ran</ForeName>    <Initials>JR</Initials>    <AffiliationInfo>      <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Bohlen</LastName>    <ForeName>Jonathan</ForeName>    <Initials>J</Initials>    <AffiliationInfo>      <Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France; University of Paris, Imagine Institute, Paris, France.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Dever</LastName>    <ForeName>Thomas E</ForeName>    <Initials>TE</Initials>    <AffiliationInfo>      <Affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. Electronic address: thomas.dever@nih.gov.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Puglisi</LastName>    <ForeName>Joseph D</ForeName>    <Initials>JD</Initials>    <AffiliationInfo>      <Affiliation>Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: puglisi@stanford.edu.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
36334601,NA,NA,"<Journal>  <ISSN IssnType=""Electronic"">1474-547X</ISSN>  <JournalIssue CitedMedium=""Internet"">    <PubDate>      <Year>2022</Year>      <Month>Nov</Month>      <Day>02</Day>    </PubDate>  </JournalIssue>  <Title>Lancet (London, England)</Title>  <ISOAbbreviation>Lancet</ISOAbbreviation></Journal>","<AffiliationInfo>  <Affiliation>Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: lrubenstein@jhu.edu.</Affiliation></AffiliationInfo>","<AuthorList CompleteYN=""Y"">  <Author ValidYN=""Y"">    <LastName>Rubenstein</LastName>    <ForeName>Leonard</ForeName>    <Initials>L</Initials>    <AffiliationInfo>      <Affiliation>Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: lrubenstein@jhu.edu.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Jalazai</LastName>    <ForeName>Rabia</ForeName>    <Initials>R</Initials>    <AffiliationInfo>      <Affiliation>Johns Hopkins Hospital Department of Internal Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Spiegel</LastName>    <ForeName>Paul</ForeName>    <Initials>P</Initials>    <AffiliationInfo>      <Affiliation>Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author>  <Author ValidYN=""Y"">    <LastName>Glass</LastName>    <ForeName>Nancy</ForeName>    <Initials>N</Initials>    <AffiliationInfo>      <Affiliation>Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; Johns Hopkins University School of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation>    </AffiliationInfo>  </Author></AuthorList>","<PublicationTypeList>  <PublicationType UI=""D016428"">Journal Article</PublicationType></PublicationTypeList>",NA
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
NA,"NA","NA","NA","NA","NA","NA","NA"
